FDA recalls Axcil and Desirin

Sep 24, 2007

The U.S. Food and Drug Administration announced the recall of two sexual enhancement products -- Axcil and Desirin -- because of undeclared, ingredients.

Axcil -- described as a "male enhancement" product -- and Desirin -- said to "promote female sexual function" -- are over-the-counter drugs distributed nationwide by TWC Global LLC of Mountain View Calif. The company initiated the voluntary recall after FDA tests found the products contain sildenafil, the active ingredient of a FDA-approved drug to treat erectile dysfunction, as well as two analogs -- sulfosildenafil and sulfohomosildenafil.

The FDA said the undeclared chemicals pose a threat to consumers because they might interact with nitrates found in some prescription drugs.

Both Axcil and Desirin are sold via the Internet in a 15-capsule blister pack packaged in a box.

Consumers with questions can contact the company at 650-575-0828.

Copyright 2007 by United Press International

Explore further: 'Beach body' ads investigated after outcry in Britain

Related Stories

Video: Why are avocados so awesome?

49 minutes ago

Whether they're in a big bowl of guacamole for your Cinco de Mayo festivities or scooped on top of your salad, avocados enjoy a special place in our hearts and stomachs. On top of being tasty, avocados are ...

Study describes revolutionary method of making RNAs

51 minutes ago

A biochemist from The University of Texas Health Science Center at San Antonio is a co-author on a paper in Nature that describes a new, more efficient method of making ribonucleic acids (RNAs).

Recommended for you

Dutch DSM posts Q1 slump

Apr 29, 2015

Dutch pharmaceutical group DSM posted a 70 million euro first quarter net loss Wednesday despite an 11 percent jump in sales, boosted by higher animal nutrition volumes and favourable exchange rates.

New meds help drugmakers weather strong dollar, other issues

Apr 28, 2015

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.